Dubai - Sharikat Mubasher: Longevium, a Dubai-based longevity clinic network and next-generation preventive healthcare ecosystem, successfully raised $7 million in its first investment round to establish a new Longevity AI Research Lab and accelerate the development of longevity technologies, diagnostics and clinical research programs.
The company started construction of the new lab at Dubai Science Park, with plans to open the facility during the fourth quarter (Q4) of 2026, according to the official statement released yesterday.
The lab will serve as a dedicated research and development hub, connecting AI, biomedical research and clinical practice to develop technologies designed to predict health risks, measure biological aging and extend healthy lifespan. It will build on technologies already in clinical use across Longevium’s network, including Doctor Deep, an AI assistant for physicians and a biological age app.
The Lab will explore new AI-driven innovations in the following areas: digital twins, regenerative medicine and tissue engineering, robotic diagnostics and next-generation wearables, and noble gas therapy.
Ksenia Butova, Founder and CEO of Longevium, said: “Our mission is to make the world’s most advanced longevity innovations accessible to more people and help create a future in which healthy human lifespans of up to 200 years may become possible.”
The new Longevity AI Research Lab will be built on Longevium’s existing clinical network of three Dubai clinics in Jumeirah 3, Jumeirah Lake Towers and Jumeirah Village Circle.
